Hypoglycemia pathophysiology

Revision as of 17:30, 17 July 2017 by Medhat (talk | contribs)
Jump to navigation Jump to search

Hypoglycemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypoglycemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypoglycemia pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypoglycemia pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypoglycemia pathophysiology

CDC on Hypoglycemia pathophysiology

Hypoglycemia pathophysiology in the news

Blogs on Hypoglycemia pathophysiology

Directions to Hospitals Treating Hypoglycemia

Risk calculators and risk factors for Hypoglycemia pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pathophysiology

RESPONSE TO HYPOGLYCEMIA IN DIABETES

Insulin[1-3,6].

the ability to suppress insulin release, cannot occur in patients with absolute beta-cell failure those with type 1 diabetes and long-standing type 2 diabetes.

inhibition of hepatic glucose production continues. Thus, the main defense against hypoglycemia is increased release of counterregulatory hormones (glucagon and epinephrine).

Glucagon 

This may be the result of beta-cell failure and subsequent loss of the hypoglycemia-induced decline in intraislet insulin that normally signals increased glucagon secretion during hypoglycemia [3,9,10].

Epinephrine 

epinephrine response to hypoglycemia also becomes attenuated in many patients, at least in part because of recent antecedent hypoglycemia [1,2,7,11]. An attenuated epinephrine response causes defective glucose counterregulation, which is associated with a 25-fold or greater increased risk of severe hypoglycemia [12,13].

An attenuated sympathoadrenal (largely sympathetic neural) response causes hypoglycemia unawareness[14].

by shifting the glycemic threshold for the sympathoadrenal response to subsequent hypoglycemia to a lower plasma glucose concentration. 4

Brain metabolism depends primarily on glucose for fuel in most circumstances. A limited amount of glucose can be derived from glycogen stored in astrocytes, but it is consumed within minutes. For most practical purposes, the brain is dependent on a continual supply of glucose diffusing from the blood into the interstitial tissue within the central nervous system and into the neurons themselves.

If the amount of glucose supplied by the blood falls, the brain is one of the first organs affected. In most people, subtle reduction of mental efficiency can be observed when the glucose falls below 65 mg/dl.

Impairment of action and judgement,Seizures may occur as the glucose falls further, resulting in coma. These brain effects are collectively referred to as neuroglycopenia.

The importance of an adequate supply of glucose to the brain is apparent from the number of nervous, hormonal and metabolic responses to a falling glucose. Most of these are defensive or adaptive, tending to raise the blood sugar via glycogenolysis and gluconeogenesis or provide alternative fuels.

This can include impairment of cognitive function, motor control, or even consciousness.

References


Template:WikiDoc Sources